About 1 result found for searched term "Ocaratuzumab" (0.123 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M24562 | Ocaratuzumab | CD20 |
| AME 133v; LY 2469298; Humanized Anti-MS4A1 Recombinant Antibody | ||
| Ocaratuzumab (AME 133v) is an Fc-engineered humanized IgG1 anti-CD20 monoclonal antibody, with a Kd of ~100 pM. Ocaratuzumab exhibits more effective antibody-dependent cell-mediated cytotoxicity (ADCC). | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
